Skip to content

Author

Yan-Lei Hao

We have 1 of 10 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Aug 2026

Clinical characteristics, management and outcomes in immune checkpoint inhibitor-induced central nervous system demyelinating disease

Patients with central nervous system demyelinating disease (ICI-CDD) should be suspected in patients receiving ICI therapy who present with unexplained paraparesis, sensory deficits, sphincter dysfunction, visual loss, or visual field defects, thereby improving clinical outcomes.

Zhong-Mian Ma, Wei-Bin Xie, Yan-Lei Hao et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.